Sort
48,018 grants matching “immunotherapy”
Cytokine Gene Therapy of Cancer - Preclinical Studies
$911,332University Of Pittsburgh At Pittsburgh · P01 · FY2005 · CA
Targeted Therapy for Leukemia
$911,328John C Byrd · Ohio State University · R35 · FY2015 · CA
Lysis-free extraction of biopharmaceuticals from the periplasm of Clean Genome E. coli
$911,189Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2019 · AI
A Human Antibody as an Immunotherapy for Cocaine Abuse
$911,120Andrew B Norman · P2d, Inc. · R44 · FY2007 · DA
CELL EXPANSION BIOREACTORS FOR ASSAY-READY IMMUNOCOMPETENT PATIENT MODELS
$911,110Kacey Ronaldson · Link Biosystems Inc. · R44 · FY2025 · CA
Targeting PD-1 Pathway for Functional Cure of AIDS
$911,104Rama Rao Amara · Emory University · R37 · FY2019 · AI
Precision quality check of immunotherapeutics via single-cell cytokine mapping
$910,459Jing Zhou · Isoplexis, Inc. · R44 · FY2018 · CA
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
$910,425Martin Cheever · Fred Hutchinson Cancer Research Center · U01 · FY2013 · CA
Center for Cancer Immunology and Immunotherapy (CCII) - Admin Core
$910,398Jun Yan · University Of Louisville · P20 · FY2025 · GM
Targeted Therapy for Leukemia
$910,045John C Byrd · Ohio State University · R35 · FY2017 · CA
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
$909,837Ronald Levy · Stanford University · R35 · FY2017 · CA
Development of a JBS HI-LO Urine DNA Kit
$909,519Zhili Wang · Jbs Science, Inc. · R44 · FY2019 · HG
INTRAVESICAL ONCOLYTIC THERAPY FOR BLADDER CANCER
$909,357Luke O. Russell · Vyriad, Inc. · R44 · FY2019 · CA
Regulatory T Cells in Autoimmune Disease
$909,305David A. Hafler · Brigham And Women'S Hospital · U19 · FY2008 · AI
Strategies for Prevention of Autoimmunity
$909,292Stanford University · U19 · FY2004 · DK
Extended half-life GlyTR1 combined with checkpoint blockade for Cancer Immunotherapy
$908,910Michael Demetriou · Glytr Therapeutics, Inc. · R42 · FY2024 · CA
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research
$908,788Xihong Lin · Harvard School Of Public Health · R35 · FY2023 · CA
High throughput CAR-T potency assay based on functional and transcriptional measurements on single cell co-cultures
$908,687Benjamin Biron Yellen · Celldom, Inc. · R44 · FY2025 · CA
Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study
$908,642Joshua Aiden Hill · Fred Hutchinson Cancer Center · U01 · FY2022 · CA
Modulating Cancer Stem Cell Signaling in Thoracic Malignancies
$907,746David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
CD180 targeted immunotherapeutic for chronic HBV in HIV infected patients
$907,661Deborah L. Fuller · University Of Washington · R56 · FY2019 · AI
The Yale Cancer Center Calabresi Immuno-Oncology Training Program (IOTP)
$907,540Harriet M Kluger · Yale University · K12 · FY2020 · CA
Specific Adoptive Immunotherapy of AML with Engineered CD8+ T Cells
$907,233Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2020 · CA
Vascular macrophages and T cells in atherosclerosis
$907,152Klaus F. Ley · La Jolla Institute For Immunology · R35 · FY2021 · HL
Clinical Trials Engine Lentiviral engineered T cells for HIV
$907,100Carl H. June · University Of Pennsylvania · U19 · FY2007 · AI